NCT05569785

Brief Summary

The purpose of this project is to assess the effects of bariatric surgery on muscle structure and function as well as investigating the feasibility of undertaking an exercise intervention post-surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 6, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

June 20, 2024

Status Verified

June 1, 2024

Enrollment Period

1.3 years

First QC Date

May 30, 2022

Last Update Submit

June 18, 2024

Conditions

Keywords

resistance exercise therapy

Outcome Measures

Primary Outcomes (5)

  • To assess the effects of bariatric surgery on skeletal muscle ultrasound thickness.

    This will be assessed using muscle ultrasound and units (mm)

    Total duration of study per participant is expected to be 13 to 14 weeks

  • To assess the effects of bariatric surgery on skeletal muscle cross sectional area (cm2)

    This will be assessed using muscle ultrasound

    Total duration of study per participant is expected to be 13 to 14 weeks

  • Assessment of percentage of patients who were retained throughout the intervention arm of the study

    To be measured as percentage.

    Total duration of study per participant is expected to be 13 to 14 weeks

  • Assessment of percentage of patients who were compliant with the intervention arm of the study. To be guided by FitBit monitor use.

    This assessment will be measured as percentage of patients who met compliance targets with the intervention arm for the study.

    Total duration of study per participant is expected to be 13 to 14 weeks

  • Assessment of number of patients who were recruited to the study

    This assessment will be measured as a simple numeric value

    Total duration of study per participant is expected to be 13 to 14 weeks

Secondary Outcomes (14)

  • Fasting glucose

    Total duration of study per participant is expected to be 13 to 14 weeks, there will be bloods taken on each in-person study day. Plan is for 3 of these days, screening bloods will be reviewed from the NHS interface.

  • Skeletal muscle architecture (fibre length)

    Total duration of study per participant is expected to be 13 to 14 weeks, ultrasounds will be performed at each in-person study day. performed on each in-person study day

  • Muscle fatigability (maximum voluntary contractions)

    Total duration of study per participant is expected to be 13 to 14 weeks, each assessment for this outcome will take place at the in-person study days.

  • Lean body mass using BIA and D3 creatine

    Total duration of study per participant is expected to be 13 to 14 weeks, each participant will be provided with the resources to facilitate these assessments at their in-person study days, urine collections will be returned later..

  • Motor control in force tracking

    Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  • +9 more secondary outcomes

Study Arms (2)

Group 1 Resistance Exercise Therapy Feasibility

ACTIVE COMPARATOR

One group who have been randomised to receive 4 weeks of Resistance Exercise Therapy to explore the feasibility of introducing such a programme in the bariatric population.

Other: Resistance Exercise Therapy

Group 2 Standard Care

NO INTERVENTION

This group have been randomised to receive standard care post surgery.

Interventions

4 weeks of Resistance Exercise Therapy. This is a 4 week resistance exercise training programme that can be completed at home. The programme is designed to be progressive. It was designed by a bariatric physiotherapist and an exercise physiologist. This exercise programme will be discussed at the screening visit, educational material will be provided to the participants who are randomised to the intervention RET group. Safety advice will be given to each eligible participant to ensure that if they feel unwell, develop chest pain/tightness, then they must seek advice from GP/urgent care if necessary. The exercises will need to be performed at least three times a week. Compliance will be monitored with Fitbit downloads at each visit. Fitbits will be worn during exercise sessions only.

Group 1 Resistance Exercise Therapy Feasibility

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obese adults (BMI greater than or equal to 35 kg/m2)
  • Age range 18-70 years old
  • Scheduled for RYGB surgery or sleeve gastrectomy surgery.
  • Ability to give informed consent

You may not qualify if:

  • Patients who are not fit or not suitable for RYGB or Sleeve Gastrectomy as per Tier 4 Bariatric Surgery MDT.
  • For those high-risk patients who are fast tracked to surgery, we will exclude patients with a NYHA \>3 or 4 heart failure status and those with end stage renal failure.
  • BMI greater than or equal to 60

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

COMAP

Derby, United Kingdom

RECRUITING

Related Publications (6)

  • Wadstrom C, Backman L, Forsberg AM, Nilsson E, Hultman E, Reizenstein P, Ekman M. Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty. Obes Surg. 2000 Jun;10(3):203-13. doi: 10.1381/096089200321643313.

    PMID: 10932257BACKGROUND
  • Alba DL, Wu L, Cawthon PM, Mulligan K, Lang T, Patel S, King NJ, Carter JT, Rogers SJ, Posselt AM, Stewart L, Shoback DM, Schafer AL. Changes in Lean Mass, Absolute and Relative Muscle Strength, and Physical Performance After Gastric Bypass Surgery. J Clin Endocrinol Metab. 2019 Mar 1;104(3):711-720. doi: 10.1210/jc.2018-00952.

    PMID: 30657952BACKGROUND
  • Haeffener MP, Ferreira GM, Barreto SS, Arena R, Dall'Ago P. Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications, improves pulmonary function and 6-minute walk distance in patients undergoing coronary artery bypass graft surgery. Am Heart J. 2008 Nov;156(5):900.e1-900.e8. doi: 10.1016/j.ahj.2008.08.006. Epub 2008 Oct 5.

    PMID: 19061704BACKGROUND
  • Li C, Carli F, Lee L, Charlebois P, Stein B, Liberman AS, Kaneva P, Augustin B, Wongyingsinn M, Gamsa A, Kim DJ, Vassiliou MC, Feldman LS. Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study. Surg Endosc. 2013 Apr;27(4):1072-82. doi: 10.1007/s00464-012-2560-5. Epub 2012 Oct 9.

    PMID: 23052535BACKGROUND
  • Santa Mina D, Clarke H, Ritvo P, Leung YW, Matthew AG, Katz J, Trachtenberg J, Alibhai SM. Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis. Physiotherapy. 2014 Sep;100(3):196-207. doi: 10.1016/j.physio.2013.08.008. Epub 2013 Nov 13.

    PMID: 24439570BACKGROUND
  • Herring LY, Stevinson C, Carter P, Biddle SJH, Bowrey D, Sutton C, Davies MJ. The effects of supervised exercise training 12-24 months after bariatric surgery on physical function and body composition: a randomised controlled trial. Int J Obes (Lond). 2017 Jun;41(6):909-916. doi: 10.1038/ijo.2017.60. Epub 2017 Mar 6.

    PMID: 28262676BACKGROUND

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A single-centre feasibility research programme
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2022

First Posted

October 6, 2022

Study Start

March 1, 2023

Primary Completion

June 30, 2024

Study Completion

December 1, 2024

Last Updated

June 20, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

No plan to do so

Locations